Experiment 68553
Worktypes
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Empty organism |
| Citation | ABDELMALEK,MF: ANGULO,P: JORGENSEN,RA: SYLVESTRE,PB: LINDOR,KD:. (2001). BETAINE, A PROMISING NEW AGENT FOR PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS: RESULTS OF A PILOT STUDY.. 96(9) |
| Amount utilized | |
| Compound isolated | |
| Disease | RESULTS OF A PILOT STUDY (N=10) SHOWED THAT BETAINE IS SAFE AND WELL TOLERATED DRUG THAT LEADS TO A SIGNIFICANT BIOCHEMICAL AND HISTOLOGICAL IMPROVEMENT IN PATIENTS WITH NONALCHOMOLIC STEATOHEPATITIS. PATIENTS RECEIVED BETAINE ANHYDROVS FOR ORAL SOLVTION TWICE DAILY FOR 12 MONTHS. |
| Dose amount | 20.0 GM |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | DAY |
| Dose expression | DOSE |
| Gender | GIVEN TO BOTH SEXES |